|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Tax Credit Sales receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Tax credit sale receivable | ||||||||||||||||||||
| Section 45Z Production Tax | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Current | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current portion of long term debt | ||||||||||||||||||||
| Short term borrowings | ||||||||||||||||||||
| Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current | ||||||||||||||||||||
| Convertible Series B Preferred Stock Subject to Mandatory Redemption | ||||||||||||||||||||
| Accrued property taxes | ||||||||||||||||||||
| Current portion of operating lease liability | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Liabilities, Noncurrent | ||||||||||||||||||||
| Senior secured notes and revolving notes | ||||||||||||||||||||
| EB-5 notes | ||||||||||||||||||||
| Other long term debt | ||||||||||||||||||||
| Series A preferred units | ||||||||||||||||||||
| Convertible Series B Preferred Stock Subject to Mandatory Redemption | ||||||||||||||||||||
| Convertible Series A Preferred Stock Subject to Mandatory Redemption | ||||||||||||||||||||
| Total series A preferred units | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Other long term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Series B convertible preferred stock, $0.001 par value; 7,235 authorized; 0 and 1,270 shares issued and outstanding each period, respectively (aggregate liquidation preference of $0 and $3,810 respectively) | ||||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||||
| Common stock, $0.001 par value; 140,000 authorized; 72,049 and 66,189 shares issued and outstanding each period, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...